Anti-resorptive agent related osteonecrosis of the jaw (ARONJ) in urological malignancies: Is the risk different between kidney and prostate cancer patients?

Bibliographic Details
Main Authors:	Y. Sakai, S Sato, T. Shindo, A. Takahashi, Y. Kunishima, R. Kato, N. Ito, M. Okada, H. Tachiki, K. Taguchi, T. Hirose, H. Hotta, H. Horita, M. Matsukawa, T. Muranaka, K. Nishiyama, A. Miyazaki, K. Hashimoto, T. Tanaka, N. Masumori
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320333164

id	doaj-f37b74629ac24792a13a72e8ca89a1da
record_format	Article
spelling	doaj-f37b74629ac24792a13a72e8ca89a1da2020-12-30T04:16:21ZengElsevierEuropean Urology Open Science2666-16832020-07-0119e1097e1098Anti-resorptive agent related osteonecrosis of the jaw (ARONJ) in urological malignancies: Is the risk different between kidney and prostate cancer patients?Y. SakaiS SatoT. ShindoA. TakahashiY. KunishimaR. KatoN. ItoM. OkadaH. TachikiK. TaguchiT. HiroseH. HottaH. HoritaM. MatsukawaT. MuranakaK. NishiyamaA. MiyazakiK. HashimotoT. TanakaN. Masumorihttp://www.sciencedirect.com/science/article/pii/S2666168320333164
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Y. Sakai S Sato T. Shindo A. Takahashi Y. Kunishima R. Kato N. Ito M. Okada H. Tachiki K. Taguchi T. Hirose H. Hotta H. Horita M. Matsukawa T. Muranaka K. Nishiyama A. Miyazaki K. Hashimoto T. Tanaka N. Masumori
spellingShingle	Y. Sakai S Sato T. Shindo A. Takahashi Y. Kunishima R. Kato N. Ito M. Okada H. Tachiki K. Taguchi T. Hirose H. Hotta H. Horita M. Matsukawa T. Muranaka K. Nishiyama A. Miyazaki K. Hashimoto T. Tanaka N. Masumori Anti-resorptive agent related osteonecrosis of the jaw (ARONJ) in urological malignancies: Is the risk different between kidney and prostate cancer patients? European Urology Open Science
author_facet	Y. Sakai S Sato T. Shindo A. Takahashi Y. Kunishima R. Kato N. Ito M. Okada H. Tachiki K. Taguchi T. Hirose H. Hotta H. Horita M. Matsukawa T. Muranaka K. Nishiyama A. Miyazaki K. Hashimoto T. Tanaka N. Masumori
author_sort	Y. Sakai
title	Anti-resorptive agent related osteonecrosis of the jaw (ARONJ) in urological malignancies: Is the risk different between kidney and prostate cancer patients?
title_short	Anti-resorptive agent related osteonecrosis of the jaw (ARONJ) in urological malignancies: Is the risk different between kidney and prostate cancer patients?
title_full	Anti-resorptive agent related osteonecrosis of the jaw (ARONJ) in urological malignancies: Is the risk different between kidney and prostate cancer patients?
title_fullStr	Anti-resorptive agent related osteonecrosis of the jaw (ARONJ) in urological malignancies: Is the risk different between kidney and prostate cancer patients?
title_full_unstemmed	Anti-resorptive agent related osteonecrosis of the jaw (ARONJ) in urological malignancies: Is the risk different between kidney and prostate cancer patients?
title_sort	anti-resorptive agent related osteonecrosis of the jaw (aronj) in urological malignancies: is the risk different between kidney and prostate cancer patients?
publisher	Elsevier
series	European Urology Open Science
issn	2666-1683
publishDate	2020-07-01
url	http://www.sciencedirect.com/science/article/pii/S2666168320333164
work_keys_str_mv	AT ysakai antiresorptiveagentrelatedosteonecrosisofthejawaronjinurologicalmalignanciesistheriskdifferentbetweenkidneyandprostatecancerpatients AT ssato antiresorptiveagentrelatedosteonecrosisofthejawaronjinurologicalmalignanciesistheriskdifferentbetweenkidneyandprostatecancerpatients AT tshindo antiresorptiveagentrelatedosteonecrosisofthejawaronjinurologicalmalignanciesistheriskdifferentbetweenkidneyandprostatecancerpatients AT atakahashi antiresorptiveagentrelatedosteonecrosisofthejawaronjinurologicalmalignanciesistheriskdifferentbetweenkidneyandprostatecancerpatients AT ykunishima antiresorptiveagentrelatedosteonecrosisofthejawaronjinurologicalmalignanciesistheriskdifferentbetweenkidneyandprostatecancerpatients AT rkato antiresorptiveagentrelatedosteonecrosisofthejawaronjinurologicalmalignanciesistheriskdifferentbetweenkidneyandprostatecancerpatients AT nito antiresorptiveagentrelatedosteonecrosisofthejawaronjinurologicalmalignanciesistheriskdifferentbetweenkidneyandprostatecancerpatients AT mokada antiresorptiveagentrelatedosteonecrosisofthejawaronjinurologicalmalignanciesistheriskdifferentbetweenkidneyandprostatecancerpatients AT htachiki antiresorptiveagentrelatedosteonecrosisofthejawaronjinurologicalmalignanciesistheriskdifferentbetweenkidneyandprostatecancerpatients AT ktaguchi antiresorptiveagentrelatedosteonecrosisofthejawaronjinurologicalmalignanciesistheriskdifferentbetweenkidneyandprostatecancerpatients AT thirose antiresorptiveagentrelatedosteonecrosisofthejawaronjinurologicalmalignanciesistheriskdifferentbetweenkidneyandprostatecancerpatients AT hhotta antiresorptiveagentrelatedosteonecrosisofthejawaronjinurologicalmalignanciesistheriskdifferentbetweenkidneyandprostatecancerpatients AT hhorita antiresorptiveagentrelatedosteonecrosisofthejawaronjinurologicalmalignanciesistheriskdifferentbetweenkidneyandprostatecancerpatients AT mmatsukawa antiresorptiveagentrelatedosteonecrosisofthejawaronjinurologicalmalignanciesistheriskdifferentbetweenkidneyandprostatecancerpatients AT tmuranaka antiresorptiveagentrelatedosteonecrosisofthejawaronjinurologicalmalignanciesistheriskdifferentbetweenkidneyandprostatecancerpatients AT knishiyama antiresorptiveagentrelatedosteonecrosisofthejawaronjinurologicalmalignanciesistheriskdifferentbetweenkidneyandprostatecancerpatients AT amiyazaki antiresorptiveagentrelatedosteonecrosisofthejawaronjinurologicalmalignanciesistheriskdifferentbetweenkidneyandprostatecancerpatients AT khashimoto antiresorptiveagentrelatedosteonecrosisofthejawaronjinurologicalmalignanciesistheriskdifferentbetweenkidneyandprostatecancerpatients AT ttanaka antiresorptiveagentrelatedosteonecrosisofthejawaronjinurologicalmalignanciesistheriskdifferentbetweenkidneyandprostatecancerpatients AT nmasumori antiresorptiveagentrelatedosteonecrosisofthejawaronjinurologicalmalignanciesistheriskdifferentbetweenkidneyandprostatecancerpatients
_version_	1724366800612753408

Anti-resorptive agent related osteonecrosis of the jaw (ARONJ) in urological malignancies: Is the risk different between kidney and prostate cancer patients?

Similar Items